TREVI THERAPEUTICS, INC. (TRVI) Operating income 2018–2025
TREVI THERAPEUTICS, INC. (TRVI) annual operating income history from SEC filings — each fiscal year as reported.
-$49.3MFY2025 · since FY2018: -$18.4M → -$49.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$49.3M | +4.3% |
| FY2024 | -$51.5M | -51.9% |
| FY2023 | -$33.9M | -13.4% |
| FY2022 | -$29.9M | +7.9% |
| FY2021 | -$32.5M | +0.0% |
| FY2020 | -$32.5M | -21.9% |
| FY2019 | -$26.6M | -44.7% |
| FY2018 | -$18.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice